Labcorp (NYSE:LH – Get Free Report) and Viemed Healthcare (NASDAQ:VMD – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.
Institutional and Insider Ownership
95.9% of Labcorp shares are held by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are held by institutional investors. 0.8% of Labcorp shares are held by insiders. Comparatively, 20.6% of Viemed Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Earnings & Valuation
This table compares Labcorp and Viemed Healthcare”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Labcorp | $13.95 billion | 2.06 | $876.50 million | $12.19 | 28.99 |
| Viemed Healthcare | $270.28 million | 1.33 | $14.93 million | $0.36 | 26.25 |
Labcorp has higher revenue and earnings than Viemed Healthcare. Viemed Healthcare is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current ratings and target prices for Labcorp and Viemed Healthcare, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Labcorp | 0 | 3 | 7 | 1 | 2.82 |
| Viemed Healthcare | 0 | 3 | 1 | 0 | 2.25 |
Labcorp currently has a consensus price target of $365.67, indicating a potential upside of 3.47%. Viemed Healthcare has a consensus price target of $14.00, indicating a potential upside of 48.15%. Given Viemed Healthcare’s higher probable upside, analysts plainly believe Viemed Healthcare is more favorable than Labcorp.
Profitability
This table compares Labcorp and Viemed Healthcare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Labcorp | 6.88% | 17.13% | 7.96% |
| Viemed Healthcare | 4.81% | 10.16% | 7.22% |
Risk and Volatility
Labcorp has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500.
Summary
Labcorp beats Viemed Healthcare on 11 of the 15 factors compared between the two stocks.
About Labcorp
Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
About Viemed Healthcare
Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Receive News & Ratings for Labcorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Labcorp and related companies with MarketBeat.com's FREE daily email newsletter.
